Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Jul 8, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell

This study aimed to evaluate the link between smoking, metabolic syndrome (MetS) and side-effects after prostate surgery. This study found smoking and MetS led to a higher risk of nocturia (waking at night to urinate).

Some background

Transurethral resection of the prostate (TURP) is a surgery used to treat urinary problems due to an enlarged prostate. It removes the prostate parts blocking the urine flow through the penis. Nocturia is an urge to urinate at night. Patients who have an enlarged prostate can have nocturia. MetS is a group of characteristics including high blood pressure, cholesterol and being overweight. 

It is unknown if MetS and smoking could lead to persistent nocturia after TURP. 

Methods & findings

This study included 102 patients. All patients had an enlarged prostate and experienced urinary symptoms, including nocturia. All patients underwent TURP. 39% of patients had MetS. 61% of patients were smokers.

After TURP, 42% of patients reported moderate to severe nocturia. 58% of patients who had MetS had this side-effect. 58% of patients who smoked also complained of this symptom. 

The bottom line

This study found that MetS and smoking increased the risk of nocturia after TURP.

The fine print

Nocturia in this study was evaluated through questionnaires. Information collected in this way is not always reliable. Further studies are needed.

Published By :

Neurourology and urodynamics

Date :

May 20, 2019

Original Title :

Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate.

click here to get personalized updates